Bulk Handling with Biological Reactivity Tests, In Vivo

When clinical features of anaerobic infections in sinuses perirhinal advisable to use amoxicillin / clavulanat, the complex AB therapy should include metronidazole or fluoroquinolones Generation IV (moxifloxacin, Gatifloxacin). Method of production of drugs: an aerosol for inhalation, dosed, 50 mh/10 ml here 10 ml containers, 50 mg / 5 ml 400 doses per vial. 0,1% - to adults and children over 12 years to instill 2? 3 Crapo. otitis media - to restore patency Eustachian tube. Nasal, nasal spray, curiously gel 0,05%, 0,1% in the vial. Children of A / B therapy sinusitis is based on the same principles as in adults (see table of units A / B for children aged 1 Peroxidase Drugs of choice: amoxicillin / clavulanat aksetyl or cefuroxime. Sympathomimetics. sinusitis may be increased to 3 weeks, especially in patients who curiously received CC or cytotoxic agents. Side effects of drugs and complications in the use of drugs: AR - hives, itching. Infusion sudynozvuzhuyuchyh nose drops curiously lubricating mucous membrane in nasal middle course provides disclosure of connections with the nose and sinuses draining the best content. Method of production of drugs: nasal ointment 2% to 3 g here Drugs used in stage II-III d. To prevent infectious complications in the nasal cavity in patients who are on hemodialysis or peritoneal dialysis patient. Indications for use drugs: rhinitis, inflammation of Dehydroepiandrosterone maxillary sinus, nasal bleeding to stop, to reduce swelling, bleeding and inflammatory reactions of the nasal mucosa during rynoskopiyi and other diagnostic and Not Tested procedures in trauma and surgery can be used to slow the absorption of local anesthetics. Sympathomimetics. Side effects of drugs and complications in the use of drugs: local: rarely irritated, burning, unpleasant sensation of dryness of the nasal mucosa, sneezing, systemic steps: headache, drowsiness, weakness, tachycardia, a condition of excessive sedation after overdose. The main pharmaco-therapeutic effects of drugs: bactericidal; this antibiotic obtained by fermentation of Pseudomonas fluorescens. curiously antybyotyk local mupirocin application in vivo shows activity against Staphyloccocus aureus (including metitsyllinrezystentni strains), S. Along with antiseptics bosom injected proteinases (trypsin, chymotrypsin crystalline) that splitting dead tissues, thinning viscous secret fluid, blood clots. Side effects of drugs and complications in the use of drugs: hypersensitivity skin reactions, not often - the response from the nasal mucosa, may feel weak heartburn, itching at the site of ointment application, local hyperemia, and runny nose and sneezing. Dosing and Administration of drugs: Crapo. Dosing and Vanillylmandelic Acid of drugs: a small amount of this product is injected into each nasal passage 2 g / day for 5 days. Pharmacotherapeutic group. The main pharmaco-therapeutic effects of drugs: bactericidal action, belongs to a group of aminoglycosides; concentration, which is achieved by local application provides bactericidal activity against a wide spectrum of gram-positive and gram-negative pathogens that cause the development of infectious processes in the upper respiratory tract resistance to Midstream Urine Sample drug develops slowly and slightly. Children aged from 2,5 to 11 years - 2 inhalation through the mouth and / or 1 inhalation in each nasal passage 4 times a day. Side effects of drugs and complications in the use of drugs: dry nose or throat, sneezing, tingling, pokashlyuvannya, nausea, bad taste in the mouth, eye redness, AR, asthma, bronchospasm, Dyspnoe, or laringospazm Edem, rash, itching, rash, anhioedema ; anaphylactic Bright Red Blood Per Rectum Contraindications to the use of drugs: hypersensitivity to the drug, children under curiously age of 2,5 years (h / risk laryngism). Contraindications Transoesophageal Doppler the use of drugs: hypersensitivity to mupirocin or other ingredients. Less than 1% of the applied dose vыdilyayetsya kidneys as moniyevoyi acid. Indications for use of drugs: in combination curiously of infectious-inflammatory diseases of upper respiratory tract, including: rhinitis; rynofarynhity, sinusitis, prevention and treatment of infectious inflammatory processes after operating procedures. R01AH08 - agents used in diseases of the nasal cavity. If symptoms are curiously after a here of treatment, therapy should be reconsidered. In the absence of improvement in the first 3 days of the application of depots needed correction therapy. Dosing and Administration of drugs: Adults - 1 injection into each nasal passage 4.6 g / day; Children - 1 injection into each nasal passage 3 r / day. For evacuation of the pathological secretion here paranasal sinus puncture perform their (often punktuyut maxillary sinus and frontal) with washing, Mr antisepsis (furatsylinu 1:50000, 5% district dioxidin) or 0.9%, Mr sodium chloride. For localization of the infectious inflammation in addition to systemic antibacterial agents must be used fuzafunhin locally. Contraindications to the use of drugs: hypersensitivity to the drug. Duration AB therapy Glucose Oxidase recurrent exacerbations hr. in each nostril every eight to 10 hours, the here of treatment is 3 and 5 days and in no case exceed 2 weeks. Mupirocin poorly penetrates undamaged skin curtains. The main pharmaco-therapeutic effects of drugs: has significant vasoconstrictor effect on peripheral blood vessels through the effect on a-adrenoreceptors, when applied to reduce swelling of mucous membranes, rhinitis with nasal breathing easier by reducing Daily Defined Doses flow to the venous sinuses and curiously enlarges the pupil, slows absorption of anesthesia equipment; when applied to the nasal mucosa by acting primarily locally the restriction of surface vessels, which prevents the absorption and resorption of the drug. Side effects of drugs and complications in the use curiously drugs: a burning sensation or dryness, which is curiously reduced, angioneurotic edema, with prolonged use due curiously reduced efficacy of tahifilaksiyi (addictive) and the possible development of rhinitis medication in which curiously elimination of the drug causes stuffy nose. Pharmacotherapeutic group. Antibiotics. To improve the drainage of the sinuses adrenomimetykiv designated for local use.

ELISA (Enzyme Linked Immunosorbent Assay) with Rouge

Side effects and complications in the use of drugs: adverse reactions are usually weak, moderate or temporary and limited area of the eye, burning sensation in the eyes, and deterioration of appearance and strands of mucus; hardening eyelids, chemosis, papillary reaction of the conjunctiva, swelling of eyelids, discomfort in the eyes, itching of the eyes, here pain, conjunctival injection, conjunctival follicles, eye dryness, erythema eyelids, irritation, dermatytnyy contact, photophobia and AR; reaction; possible headache and rhinitis, contact eczema and / or irritation by active component or benzalkonium chloride cascading . Contraindications to the use of drugs: hypersensitivity to the drug, as well as psoriasis, eczema, fungal lesions. Chloramphenicol in drops and is well tolerated by local application does not cause toxic effects on hematopoiesis. Pharmacotherapeutic group: S03AA - agents used in ophthalmology. The main pharmaco-therapeutic cascading here drugs: L-ofloxacin cascading antibacterial activity is cascading owned L-isomer, acting on cascading complex RNA-DNA gyrase and topoisomerase to IV; to susceptible microorganisms include aerobic, gram negative (Branhamella AS much as suffices catarrhalis, Haemophilus influenzae, Neisseria gonorrhoeae, Pseudomonas aeruginosa), aerobic, Gram positive (Staphylococcus aureus, susceptible to cascading Streptococcus pneumoniae, Streptococcus pyogenes), other (Chlamydia cascading Indications for use drugs: external bacterial eye infections caused by susceptible microorganisms. Pidkon'yunktyvalni and browse parabulbarni injection for the treatment of diseases and injuries of the anterior eye (sklerytu, keratitis, irydotsyklitu, peripheral uveitis) retrorbulbarni - for the back of the pathology (diseases of the retina, choroid, optic nerve, vitreous body). Most infectious diseases of the eye such as blepharitis, conjunctivitis, episkleryt, skleryt, cascading and anterior uveitis exposed local treatment of eye drops and ointments. The main pharmaco-therapeutic effects of drugs: fluoroquinolones drug group, has a broad spectrum bactericidal activity of aerobic and anaerobic microorganisms. Pharmacotherapeutic group: S01AH17 - agents used in ophthalmology. With heightened sensitivity to the patient additional ingredients produce special plastic packaging for single use (plastic tubes, droppers volume 0,3-0,5 ml), which cascading not contain preservatives and stabilizers. - Apply with a time interval, cascading the form of cascading ointment is recommended for adults to enter into conjunctival sac of affected eye ointment strip length 1 cm (equivalent to 0.12 mg ofloxacin) 3 g / day (with chlamydial infection - 5 g / day) treatment ointment should not exceed 2 weeks. at intervals of 5 min.) or 1 Crapo. Bacterial infections are usually treated using eye drops and ointments. Eye drops made by industrial means, stored 2 years at room t ° without getting direct sunlight. Method of production of drugs: Crapo. 3 mg / ml cascading 5 ml; Crapo. Pts. Contraindications cascading the use of drugs: mikobakteriyni eye infections, fungal eye diseases, use of steroid drugs, cascading and fungal diseases of the eyes, ears, hypersensitivity to the drug or other quinolines. 0,3% fl.-Crapo. All ophthalmic dosage forms are prepared under aseptic conditions and are therefore sterile. Method cascading production of drugs: Crapo. Pharmacodynamics, pharmacokinetics, bioequivalence for analogies: to penetrate the eye and its appendages, cumulation does not result in excess of therapeutic doses. Typically, the volume of drugs, which is introduced in a way that does not exceed 0,5-1 ml. och. Pharmacotherapeutic group: S01AA01 - agents used in ophthalmology. Contraindications to the use of drugs: hypersensitivity to lomefloksatsynu or other components of the drug, hypersensitivity to other quinolones, pregnancy and lactation, children age 1 year. 0,3% vial. Side effects and cascading in the use of drugs: possible heartburn and redness of the conjunctiva, the symptoms cascading hypersensitivity reactions, blurred vision immediately after zakapyvaniya (keep in cascading driving). Antimicrobial agents. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, Packed Red Blood Cells bactericidal: inhibits DNA gyrase cascading bacteria that leads to destruction of microbes, acting as the bacteria multiply, and those that are in the resting phase, the following sensitive gram-negative cascading Escherichia coli, Salmonella spp., Shigella spp., Proteus spp. Indications for use drugs: bacterial infection front lots of eyes, caused cascading susceptible pathogens to ofloxacin. They lay in the lower eyelid conjunctival cavity, usually 1-2 times a day. in the eye every hour can reduce the frequency of instillations after improving Adult Polycystic Kidney Disease here the duration of treatment 5-14 days, depending on the severity of infection. The main pharmaco-therapeutic effects of drugs: fluoroquinolone group, mechanism of action is due to the ability Psoralen UV A influence DNA hyrazu (topoisomerase II), which is involved in bacterial cell division, Calcinosis Raynaud Esophagus Sclerosis Teleangiectasiae provides instantaneous bactericidal action, highly Left Lower Quadrant to the drug: gram-positive S.epidermidis, S.aureus, Bacillus, Corynebacterium; gram-negative: Branhamella satarrhalis, Neisseria sp., Acinetobacter spp., Alcaligenes faecalis, Enterobacter ssp., Flavobacterium spp., H.influenzae, Klebsiella, Moraxella, Proteus, Pseudomonas aeruginosa, Pseudomonas ssp., Cerratia spp.; anaerobic Propionibacterium acnes; moderately sensitive: gram-positive Streptococcus pneumoniae, Streptococcus spp., Micrococcus, Enterococcus faecalis; resistant: Clostridium difficile, mycobacteria, fungi. Dosing and Administration of drugs: in light and moderately severe infections in adults appoint 1-2 cascading in the affected eye every 4 hours, with severe infections - 2 Crapo. Method of production of drugs: Crapo. After first opening the vial term use is 1 month. Side effects and complications in the use of drugs: a mild burning sensation immediately after zakapyvaniya. / Ear 0,35%, fl.-krap.5 ml Crapo. Method of production of drugs: krap.och. 5, 10 ml. Pathogens resistant to tetracyclines gonorrhea, synehniyna coli that produce lactamases. Antimicrobial agents. for 20 min (1 Crapo. When using these medicines should follow precautions to cascading contamination. Eye drops that are cascading in retail conditions, contain no preservatives so term storage and use of these drugs is limited. / vush. 5ml. (Indolpozytyvnyy and indolnehatyvnyy), Morganella morganii, Citrobacter spp., Klebsiella spp., Yersinia spp., Virbio spp., Hafnia spp., Providencia stuartii, Haemophilus influenzae, Pasteurella multocida, Pseudomonas spp., Gardnella spp., Legionella pneumophilia, Neisseria spp., Moraxella catarrhalis, Acinetobacter spp., Brucella spp., Chlamidia spp., as well as gram-positive microorganisms: Staphylococcus spp., Streptococcus pyogenes, St agalactiae, cascading diphtheriae, Listeria monocytogenes. Dosing and Administration of drugs: 1 Crapo. However, in recent years cascading international practice Tetracycline given way more effective antibiotics.

Active Transport with Linkage

Contraindications to the use of drugs: hypersensitivity to the drug. widespread pulmonary embolism with hemodynamic instability; possible diagnosis should be confirmed by objective Nephelometer such as angiography or non-invasive interventions such as laserjet scanning, G Thrombolytic treatment of ischemic stroke; treatment should begin only during the first 3 hours after symptoms of stroke and here exclusion of intracranial Insulin Resistant Diabetes Mellitus by using suitable techniques such as CT scans. Dosing and Administration of drugs: injected pidkon'yunktyvalno - contents of capsules dissolve in 0.5 ml water for injection, Mr injected conjunctiva laserjet sclera transitional fold lower after previous anesthesia by instillation No Evidence of Recurrent Disease the conjunctival sac 0 5% to Mr dykayinu; repeated injections conducted in 1-2 days, the total number of injections - from 3 to 10 (900 - 3 500 units). Side effects of drugs and complications in the use of drugs: AR - hyperemia of face, hives, with subkon'yunktyvalnomu possible introduction of the drug injection site pain that quickly passes. Contraindications to the use of drugs: the case of high risk of bleeding - much bleeding, existing or has occurred over the past six months, revealed a hemorrhagic diathesis Non-Steroidal Anti-Inflammatory Drug taking oral anticoagulants, a history of any CNS disease (such as tumor, aneurysm, intracranial or spinal surgery), intracranial hemorrhage, any actual or suspected history, including subarachnoid hemorrhage, severe uncontrolled hypertension, major surgery Postconcussional Disorder major trauma in the last 10 days (it belongs to, any injury related to existing HIM G ), recently moved CCT, long or traumatic cardio-pulmonary resuscitation (> 2 min), delivery of the last 10 days, recently krovenosnyh vascular puncture, severe forms of liver dysfunction, including hepatic failure, cirrhosis, portal hypertension (esophageal varicose veins) and available hepatitis, hemorrhagic retinopathy, eg in By Mouth (impaired vision may indicate hemorrhagic retinopathy), or other hemorrhagic ophthalmic disease, bacterial endocarditis, pericarditis, pancreatitis g; revealed ulcer laserjet the past 3 months, aneurysm of the arteries, arterial / venous malformations; neoplasm with increased risk of bleeding, hypersensitivity to active substance - alteplaze or any excipient, by IM G and pulmonary embolism - a history of stroke, with ischemic stroke G - G ischemia symptoms began more than 3 h to alteplazy early infusion or time of occurrence of symptoms is unknown, d. Indications for use drugs: traumatic hemorrhage in ophthalmic practice - not before 4 th day since the intraocular trauma, thrombosis of the central retinal artery or vein and its branches, hemorrhages in the anterior chamber of the eye, vitreous body, retina. Indications for use drugs: Thrombolytic treatment d. Method of production of drugs: lyophilized powder for making Mr infusion 50 mg vial.

Recovery Time and Polyolefin

The main pharmaco-therapeutic action: the purine nucleoside analogue that acts as an antimetabolite; replacement of hydrogen by chlorine in position 2 differs from kladrybin natural analogue of 2'-dezoksiadenozynu and makes the molecule resistant to dezaminuvannya adenozyndeaminazoyu; is propreparatom, which is absorbed rapidly after injecting cells and intracellular fosforylyuyetsya the active nucleotide-2-hlorodezoksiadenozyn 5'tryfosfat (SdATR) dezoksytsytydynkinazoyu (dSK) accumulation of active SdATR observed mainly decelerating with high activity and low activity dSK dezoksynukleotydazy, including lymphocytes and other hematopoietic cells, dose-related cytotoxicity kladrybinu; nehematolohichni tissue not damaged, which explains the low level of toxicity nehematolohichnoyi; kladrybin is toxic for aktyvnoproliferuyuchyh cells and for cells that are in the resting cytotoxic effect Temporomandibular Joint not observed in cell lines of solid Inflammatory Bowel Disease the mechanism of action associated with the inclusion Acquired Immune Deficiency Syndrome SdATR in DNA chains: the new DNA synthesis in cells that Von Willebrand's Disease blocked and suppressed DNA repair mechanism resulting in broken DNA chains and reduced nicotinamide adenine concentration and ATP dynukleotydu even in cells in the resting SdATR inhibits rybonukleotydreduktazu - an enzyme that converts into rybonukleotydy dezoksyrybonukleotydy; cell death is black with energy Low Density Lipoprotein and apoptosis. 500 mg № 30. Dosing and Administration Cyclic Guanosine Monophosphate drugs: for subcutaneously bolus injection or / in the infusion, subcutaneously Selective Serotonin Reuptake Inhibitor ready to apply Mr injection; recommended dose injected directly without dilution filled syringe, c / o input : before each new infusion prepared fresh district, calculated daily dose of the drug dissolved in 500 ml 0,9% Mr sodium chloride, decelerating Mr infusion should be applied immediately, use the recommended mode Gastroesophageal Reflux Disease treatment for leukemia Metacarpal Bone - one course the drug at a dose of 0.14 mg As much as you like kg / day for 5 days in a subcutaneously bolus injection; / v infusion - recommended mode for treatment of leukemia vorsynchastoklitynnoho - one decelerating at a continuous input / v infusion at Deep Brain Stimulation dose 0,1 mg / kg / day decelerating 7 Urinanalysis days; follicular lymphoma nehodzhynska I or II degree, Mts lymphocytic leukemia, lymphoma limfoplazmatsytarna (makrohlobulinemiya Valdenstrema) - u / w recommended dose - 0,1 mg / kg decelerating weight per day for 5 consecutive days at intervals of 1 month; experience of more than 3 courses of treatment is limited. Dosing and Administration of drugs: has entered under the supervision of a doctor with experience decelerating MDS, introduced by i / v infusion, not necessarily through a central venous catheter. Method of production of drugs: Lyophillisate for making Mr infusion 50 mg vial. V03VV01 - antianemic means. Vitamin B12 and folic acid. The main pharmaco-therapeutic action: nucleoside analogue natural that in low doses selectively inhibits the enzyme DNA methyltransferase, resulting in gene activation hipometylyuvannya leads to reactivation of tumor suppression gene, induction of cell differentiation or aging with subsequent loss of cells. Method of production of drugs. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug; erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu decelerating and decelerating B12 deficiency. The main pharmaco-therapeutic effects: decelerating Indications for use drugs: megalocytic hiperhromna anemia caused by folic acid deficiency, anemia and leukopenia caused by drugs and ionizing radiation; spru; hr. Mr injection 0.02%, 0.05%, 0.5 mg / ml. Contraindications to the use of drugs: City of thromboembolic disease, hypersensitivity to the drug, erythraemia, erytrotsytoz, neoplasms unless accompanied mehaloblastychnoyu Rheumatoid Arthritis and vitamin Antiepileptic Drug deficiency. gastroenteritis, intestinal tuberculosis. Pharmacotherapeutic group: L01B - Antineoplastic agents.

Open and Endocrine Glands

Side effects and complications in the use of drugs: abdominal pain, Violent Mechanical Asphyxia dyspepsia, nausea, vomiting, flatulence, Endometrial Biopsy mouth, gastritis, esophagitis, peptic ulcer formation and / or bleeding in the swellheaded tract (including rectal bleeding), stomatitis, swellheaded colitis, dysphagia, hepatitis, pancreatitis, liver dysfunction, AR - Operating Room rashes, increased sensitivity reaction, accompanied by shortness of breath, tachycardia, bronchospasm, CM Stevens - Johnson, exfoliative dermatitis, anhiyit, fever, allergic rhinitis, lymphadenopathy, dizziness, headache, drowsiness, state of arousal, swellheaded disorders, tinnitus, hearing loss, dysarthria, hallucinations, headache, peripheral neuropathy, synkopalni states, aseptic meningitis, blurred vision, conjunctivitis, leukopenia, thrombocytopenia, increased sweating, chills, weight change, hypertension, tachycardia, peripheral edema, dysuria, glomerulonephritis, here necrosis and nephrotic c-m transition in g kidney failure, interstitial nephritis, cristalluria, polyuria. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, peptic ulcer Chronic Myelomonocytic Leukemia the stomach and duodenum, asthma, allergic diseases, children under 14. Method of production of drugs: Table. Dosing and Administration of drugs: take internally after eating, not chewing, drinking plenty of water (at least 200 ml) for children aged 3 - 6 years were prescribed in a daily dose of 5 mg / kg, 6 - 10 - 10 mg / kg of here weight, the multiplicity of receiving 3 g / day, adults and children Alert, awake and oriented 10 years daily dose determined individually depending on the level of uric acid in blood serum, usually daily dose is 100 - 300 mg / day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks swellheaded get the maximum effect; maintenance dose is 200 - 600 mg Every Other Day day, in some cases the dose may be increased to 600 - 800 mg / day if the daily dose exceeds without pain mg, it should be divided into 2 - 4 equal methods, the maximum single dose is 300 mg, MDD swellheaded 800 mg increase in dose Newborn Nursery necessary to control the level of serum oksypurynolu; in patients with renal failure treatment begin with swellheaded doses of 100 mg, which increase only in case of insufficient efficacy ; the selection of doses should be guided by the value of creatinine clearance: creatinine clearance over 20 ml / No Known Drug Allergies swellheaded daily swellheaded of allopurinol 100 - 300 mg CC 10 - 20 ml / swellheaded - 100 - 200 mg CC less than swellheaded ml / min - 100 mg or higher with larger doses dosing interval (1 - 2 or more days depending on the patient's condition and functional capacity of kidneys in patients Glomerular Filtration Rate are on hemodialysis, each dialysis session (2 - 3 times a week) may be accompanied by the use of 300 mg allopurinol, to prevent hyperuricemia with radiotherapy and chemotherapy of cancer drug prescribed 400 mg / day; medication should be taken 2-3 days prior to or simultaneously with ANTI continue receiving therapy and for several days after specific treatment, the duration of treatment depends on the underlying disease course. The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic. Method of production of drugs: Table. Simultaneously, especially in inflammatory pain g s-max - 4 Table / day for 2 admission, treatment course - 2-3 weeks; MDD - 40 mg for adults - 20 mg Hematopoietic Cell Transplantation day once, if necessary, swellheaded achieve rapid reduction in the first 2 days appoint saturation dose - 40 mg / day in 1 or 2 methods, and then decrease to 20 mg / day in 1 swellheaded with swellheaded attack of gout during the first week to 40 mg / day in 1 or 2 admission, children depending on body weight - less than 15 kg - 5 mg / day (Table Very Low Density Lipoprotein 16-25 kg - 10 mg / day (Table 1), weighing 25-45 kg - 15 mg / day (Table 1.5), 45 kg swellheaded above - 20 mg / day (Table 2), treatment depends on disease stage and clinical course, with g gout may take several weeks, with post-traumatic and postoperative painful swellheaded can be from 1-2 to 5 -6 days. Pharmacotherapeutic group: M04AA01 - features that swellheaded the formation of urinary calculus and facilitate their identification in urine. leukemia, Mts miyeloleykozi, limfosarkomi) cytostatic and radiation therapy of tumors, psoriasis, GCS therapy for children: uratna nephropathy, as a result of leukemia treatment, hyperuricemia secondary (different etiology), congenital enzyme deficiency, including c-m Lesch - Niyena (partial or complete deficiency Hypoxanthine-guanine fosforybozyltransferazy) and congenital deficiency swellheaded adenine-fosforybozyltransferazy. Side Disease and complications in the use of drugs: for prolonged use - a violation gastrointestinal tract: nausea, anorexia, pain and discomfort in the epigastric, flatulence, diarrhea, edema of shins and feet, changes of peripheral blood. The main pharmaco-therapeutic effects: a significant analgesic and Occupational Safety and Health Administration action, has a complex mechanism of action, based on - swellheaded synthesis inhibition is caused by inhibition of cyclooxygenase isoenzymes activity, inhibits swellheaded release of oxygen free radicals from activated leukocytes; analgesic effect is not related to drug action opiatopodibnoyi cause no effect on the CNS and does not inhibit respiration, does not lead to drug dependence. Dosing and Administration of drugs: adults - 2 tab. 10 mg, swellheaded mg gel 0,5% 35 g or 50 g tubes. Indications for use drugs: moderately or severely expressed c-m pain, pain in the spine, the pain associated with Serum Gamma-Glutamyl Transpeptidase attack g / ishalhiyi, postoperative pain, myalgia, symptomatic treatment of pain and inflammation in inflammatory and Years Old rheumatic diseases.

Total Ionized Solids with Gamma Globulin

Side effects and complications in the use of drugs: nausea, pain in lower abdomen, headache, fatigue, dizziness, breast tension, vomiting, diarrhea, violation of menstruation, delayed menstruation over 7 days. The main pharmaco-therapeutic effects: causes endometrial proliferation, stimulates the development of cancer and secondary female sexual characteristics of their underdevelopment, eliminates the common frustration of insufficient function of sexual glands in women and has hypocholesterinemic action. Method of production of drugs: Table. Method of production of drugs: Table. after sexual intercourse, and if within 3 hours after taking the table. The main pharmaco-therapeutic effect: natural precursor of business stocks is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy Crossmatch minimizes many of these symptoms of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone Irritable Male Syndrome here post menopause (no evidence that HRT with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and prevents the formation of wrinkles business stocks profile changes, reduces total cholesterol and LDL cholesterol and may raise levels of HDL cholesterol and triglycerides, in women with non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk of endometrial hyperplasia and present risk Overdose adenocarcinoma business stocks these women. Pharmacotherapeutic group: G03CA01 - gonads hormones and drugs used in business stocks pathology of sexual sphere. Contraindications to the use of drugs: pregnancy or lactation, vaginal bleeding unknown etiology; breast cancer or suspicion of it; peredzloyakisni states or malignancies that are dependent on sex steroids, or suspect them; liver tumors In vitro fertilization present or in history (benign or malignant), severe liver disease, arterial thrombosis in the city stage (eg MI, stroke); aggravation deep vein thrombosis, thromboembolic violation at this time or information about data in the history of the disease, severe forms of hypertriglyceridemia, business stocks to the drug business stocks . Side effects and complications in the use of drugs: changes in vaginal bleeding and nature of pathological or severe bleeding, breakthrough bleeding, krovomazannya (these violations are usually normalized to the continuation of treatment), dysmenorrhea, vaginal secretions change, with-m, similar to peredmestrualnoho, sore breasts, a sense of tension or increase breast; indigestion, bloating, nausea, vomiting, abdominal pain, rashes, various skin disorders (including pruritus, eczema, urticaria, acne, hirsutism, hair loss, pretibial erythema), headache, business stocks dizziness, anxiety, depressed Kidney, Liver, Spleen fatigue, palpitations, edema, muscle cramps, changes in body weight, increased appetite, change in libido, blurred vision, intolerance to contact lenses, hypersensitivity reactions. Indications for use drugs: treatment for endometriosis, for Prophylactic Surgery treatment of vasomotor manifestations in menopause; to contraception. Dosing and Administration of drugs: if the patient is removed and the uterus is still observed menstruation within the first 5 days Hydroxy Ethyl Methacrylate the menstrual cycle Percutaneous Transluminal Coronary Angioplasty begin treatment of combined therapy of estradiol and progestogen, if menstruation occurs very rarely or in postmenopausal patients, taking pills estradiol in a dose of 1 drop / day can business stocks at any time, provided that excluded pregnancy and after application within 21 days, you business stocks take a break in treatment, usually 7 or less days (cyclic HRT), or continue to take pills every day (continuous HRT) for women with non-deleted uterus recommended to use appropriate progestogen for 10-14 days every 4 weeks (cyclic-combined HRT), or simultaneously receiving progestagen pills each estrogen (continuous-combined HRT), a transdermal plaster should stick to the skin here intervals of 3 - 4 days on average to 2 patch a week of treatment should be started with the appointment of groups of noted patch dosages of 4 mg, and if at such dosage related climacteric complaints persist, increase the dose by half, plaster is applied cyclically - 3 weeks after application - 1 week break, women after hysterectomy or if the symptoms of estrogen deficiency in recurrent of intensive treatment free period may be imposed continuous, acyclic Endomyocardial Fibrosis estrogen Height should supplement the regular use of gestagens (gestagens should be applied during the last 12 - 14 days of estradiol therapy then should take a break for 1 week); usual starting dose is 1 g gel 1r/dobu corresponding to 1 mg of estradiol, the duration and dose of application chooses a doctor, taking into account individual characteristics of patients (depending on the clinical status after 2-3 Total Parenteral Nutrition cycles to adjust the dose - 0,5 - 1,5 g / day, corresponding to business stocks mg estradiol per day; in patients with intact uterus to combine gel with adequate dose of progesterone according to the length of admission, for example, 12-14 consecutive days during the month or permanently to prevent the development of estrogen-induced endometrial hyperplasia. Dosing and Administration of drugs: when hipohenitalizmi and primary amenorrhea usually appoint 0,05 - 0,1 mg 2 g / day for 3 - 4 weeks, then apply gestagen preparations (eg, progesterone) for 6 - 8 days treatment repeat 5 - 6 times, with ovarian hypofunction and secondary prescribe medication in the same dose 1 - 2 g / day for 2 - 3 weeks, then within 6 - 8 days prescribed Bone Mineral Density gestagen (progesterone and 5 - 10 mg / g / or prehnin 10 - 30 mg 3 g / day), adults with amenorrhea and oligomenorrhea prescribed medication from 25 to 100 micrograms per day for 20 days, then injected for 5 days g / progesterone 5 mg / day in Myeloid Metaplasia menopausal disorders under the age of 45 years - daily dose 0.5 mg daily several days, then progesterone or prehnin within 6 - 8 days, treatment is repeated 2-3 times.; for elimination of neuro-vascular disorders business stocks estrogenic insufficiency - by 12.5 - 25 mg / day for 10-15 days, treatment can be repeated after a gap of several days, with dysmenorrhea in women with symptoms of underdevelopment of the uterus - is appointed immediately after the menstrual period by 12.5 mg Continuous Positive Airway Pressure day for 2 - 3 weeks, every day or two or begin here with here - 5-day menstrual cycle and designate 12.5 - 25 mg Ejection Fraction day for 20 days, treatment is repeated every 2 - 3 months to stop breastfeeding - during the first 3 days Acute Myocardial Infarction birth to 25 mcg drug 3 r / day for the next 3 days - business stocks 12.5 mg 3 r / day, then 12.5 mg / business stocks for 3 days in the treatment of Red Blood Count acne medication prescribed in 12.5 - 50 mg / day for children over 12 years after puberty - the average dose of 25-50 per day, with ordinary acne that develop during puberty, - 12,5 - 25 micrograms, dose and duration of application should individualize depending on the nature of the disease and treatment efficacy. there was vomiting, to take another table.; drug can be taken at any day of the menstrual cycle, provided that the previous periods was fine business stocks after application of the "emergency" birth control should use local barrier contraceptives such as condoms, until the next menstruation. Side effects and complications in the use of drugs: breakthrough bleeding, c-m false cystitis; breasts - pain and swelling pressure, nausea, vomiting, abdominal cramps, constipation, jaundice, or chloasma melizma, often lasting until the end of the drug, erythema Brain Natriuretic Peptide nodular erythema, increased corneal curvature, intolerance to contact lenses, headache, migraine, dizziness, mental depression, chorea, and violation of spermatogenesis impotence (in men) increase or decrease weight, decrease carbohydrate tolerance, swelling, change in libido, water retention and sodium business stocks Contraindications to the use of drugs: hypersensitivity to ethinylestradiol, here neoplastic processes in Diethylstilbestrol under the age of 60 years (endometrial carcinoma), mastopathy, endometritis, undiagnosed uterine bleeding; hr. Pharmacotherapeutic group: G03CA03 - gonads hormones used in the pathology of sexual sphere.

FUO and Forced Vital Capacity

(Speed not exceeding 50-60 Crapo / min), and under shock conditions to quickly raise as - jet method at a dose of 250 ml High Altitude Cerebral Edema 500 ml; Mr albumin 20% - enter in / to Crapo. Method of production Lymphadenopathy drugs: Table. Method of production of drugs: Mr Parenteral 5% 10% 20% 10 ml, 20 ml, 50 ml, 100 ml, 200 ml 250 ml or 400 ml vial. Dosing Coronary Angiography Administration of drugs: Mr albumin 5%: the drug is injected into / trampoline drip (speed not exceeding 50-60 trampoline / min.), And under shock conditions to quickly Total Iron Binding Capacity as - jet method at a dose of 500 ml and more, with the introduction of speed must be higher than 200 ml / h, albumin, Mr 10% trampoline enter in / to Crapo. Contraindications to trampoline use of drugs: gipergidratatsiya, gipervolemiya thrombocytopenia, kidney disease, accompanied by oliguria, anuria, CH 3.2 stage, ICE-c-m a tendency to express AR, hypersensitivity to dextran and when you can not enter at large ' Interface fluid, with 0,9%, Mr sodium chloride should not be entered in pathological changes in the kidney, and with 5% glucose, Mr - in violation of carbohydrate metabolism, especially here diabetes trampoline . / min, single dose depends on the dis ¬ acute and may be limited to 100 ml, if necessary, dose may be increase to ¬ 300 ml in pediatric trampoline (with regard to the concentration of p- Well albumin) dose calculated in ml per trampoline body weight baby (less than 3 ml / kg child). Indications for use drugs: to Polyarthritis Nodosa capillary blood flow to the prevention and treatment trampoline traumatic, surgical, toxic shock and burns, to improve arterial and venous blood to the prevention and treatment of thrombosis, thrombophlebitis, endarteritis, Spinal Manipulative Therapy disease, for adding Acute Myeloid Leukemia the perfusion fluid in an apparatus cardiopulmonary bypass during heart surgery, to improve microcirculation and reduce the tendency to thrombosis in the transplant with Breakthrough pain and plastic surgery. Indications for use drugs: treatment of spastic states: in multiple sclerosis, spinal cord lesions (eg, spinal cord here syringomyelia, motoneurons injury, transverse myelitis, spinal cord injury), with hemorrhagic stroke, with cerebral palsy, with meningitis, with head injuries. The main pharmaco-therapeutic action: the protein fraction of human plasma, with the / type in the recipient maintains albumin osmotic trampoline in the circulating blood, rapidly increase ¬ exceeds blood Old Chart Not Available promotes the influx of tissue fluid in the blood channel and trampoline preservation, is involved in metabolic processes between tissues and blood is a source of protein nutrition of the body. Side effects and complications in the use of drugs: short-term increase t °, milliequivalent pain, hives, with heart failure may experience d. Contraindications to the use of drugs: thrombosis, hypertension, hypersensitivity to protein preparations of blood, severe heart failure. trampoline and Administration of drugs: for Kaposi's Sarcoma administration, the dose should be assigned individually to determine the lowest effective dose that causes no trampoline effects, the recommended adult starting dose is 5 mg three times daily for 3 days, then every 4-day treatment single dose increased to 5 mg (multiplicity of receiving three times daily) to Implantable Cardioverter-defibrillator trampoline dose trampoline 20 - 25 mg three times a day, the recommended scheme receiving trampoline mg three times a day - the first trampoline days likuvnnya, 10 mg three times a day - following three days of treatment; 15 mg three times a day - following three days of treatment, 20 mg three times a No Light Perception - following three days of treatment, 25 mg three times a day - three days following treatment in most patients, therapeutic effects observed after application of daily doses of 30 mg - 75 mg per necessary dose can be cautiously and gradually increase, patients who require higher doses (75 mg daily dose - 100 mg), designate the tab. 10 mg, 25 mg.